Quick Answer
Mirum Pharmaceuticals, Inc. reported Net Income Loss of -$23.36 million for the year ending 2025.
- Mirum Pharmaceuticals, Inc. showed an increase of +73.4% in Net Income Loss from 2024 to 2025.
- This data is from Mirum Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2019 to 2025), Mirum Pharmaceuticals, Inc.'s Net Income Loss has grown by 55.5%.
- Historical annual values: Fiscal year 2025: -$23.36 million | Fiscal year 2024: -$87.94 million | Fiscal year 2023: -$163.42 million | Fiscal year 2022: -$135.67 million | Fiscal year 2021: -$83.99 million | Fiscal year 2020: -$103.27 million | Fiscal year 2019: -$52.55 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: